{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026#webpage",
"url": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026",
"name": "Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2026",
"description": "his Fortrea infosheet explores how oncology clinical development is evolving through precision medicine in oncology, biomarker-driven research, and modern cancer drug development strategies across multiple oncology therapeutic areas. The content compiles scientific articles and clinical insights focused on oncology biomarkers, molecular oncology profiling, personalized cancer treatment approaches, and biomarker-led clinical trials within precision oncology research environments. The infosheet highlights how targeted cancer therapies and oncology evidence generation are increasingly influencing clinical development strategies, translational research integration, and individualized therapeutic decision-making across oncology programs. Fortrea oncologists discuss ongoing advancements in cancer drug development, biomarker research, and precision medicine approaches that are shaping future oncology clinical development and treatment innovation. By integrating oncology evidence generation with precision oncology research and biomarker-focused development strategies, the infosheet provides insights into current trends influencing cancer drug development and personalized oncology treatment approaches."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2026",
"item": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026#webpage"
},
"headline": "Oncology Research Insights on Precision Medicine and Biomarker-Driven Therapies | Fortrea Infosheet",
"description": "his Fortrea infosheet explores how oncology clinical development is evolving through precision medicine in oncology, biomarker-driven research, and modern cancer drug development strategies across multiple oncology therapeutic areas. The content compiles scientific articles and clinical insights focused on oncology biomarkers, molecular oncology profiling, personalized cancer treatment approaches, and biomarker-led clinical trials within precision oncology research environments. The infosheet highlights how targeted cancer therapies and oncology evidence generation are increasingly influencing clinical development strategies, translational research integration, and individualized therapeutic decision-making across oncology programs. Fortrea oncologists discuss ongoing advancements in cancer drug development, biomarker research, and precision medicine approaches that are shaping future oncology clinical development and treatment innovation. By integrating oncology evidence generation with precision oncology research and biomarker-focused development strategies, the infosheet provides insights into current trends influencing cancer drug development and personalized oncology treatment approaches.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-03/fortrea-oncologists-published-2020-2025.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-17",
"dateModified": "2025-03-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/fortrea-oncology-articles-2020-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}